D. E. Shaw & Co., Inc. Jazz Pharmaceuticals PLC Transaction History

D. E. Shaw & Co., Inc.

$100 Billion
Q1 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 66,191 shares of JAZZ stock, worth $7.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

66,191

Previous 302,109 78.09%

Holding current value

$7.33 Million

Previous $37.2 Million 77.91%

% of portfolio

0.01%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$120.07 - $144.17 $28.3 Million - $34 Million	-235,918 Reduced 78.09%	66,191 $8.22 Million
Q4 2024 Feb 14, 2025	BUY	$107.32 - $127.74 $4.69 Million - $5.58 Million	43,710 Added 16.92%	302,109 $37.2 Million
Q3 2024 Nov 14, 2024	BUY	$100.57 - $116.37 $254,240 - $294,183	2,528 Added 0.99%	258,399 $28.8 Million
Q2 2024 Aug 14, 2024	BUY	$103.94 - $118.98 $5.02 Million - $5.74 Million	48,270 Added 23.25%	255,871 $27.3 Million
Q1 2024 May 15, 2024	SELL	$115.19 - $132.77 $5.32 Million - $6.13 Million	-46,194 Reduced 18.2%	207,601 $25 Million
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $2.91 Million - $3.46 Million	25,462 Added 11.15%	253,795 $31.2 Million
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $5.05 Million - $6.01 Million	-41,387 Reduced 15.34%	228,333 $29.6 Million
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $16.2 Million - $19.4 Million	132,137 Added 96.04%	269,720 $33.4 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $5.66 Million - $6.78 Million	42,247 Added 44.31%	137,583 $20.1 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $12.4 Million - $15.2 Million	95,336 New	95,336 $15.2 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $49,626 - $60,307	414 Added 7.32%	6,068 $773,000
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $1.59 Million - $2.29 Million	-12,374 Reduced 68.64%	5,654 $736,000
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $213,706 - $248,684	1,334 Added 7.99%	18,028 $3.2 Million
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $587,092 - $678,211	3,909 Added 30.57%	16,694 $2.74 Million
Q4 2020 Feb 16, 2021	SELL	$140.71 - $165.05 $290,144 - $340,333	-2,062 Reduced 13.89%	12,785 $2.11 Million
Q3 2020 Nov 16, 2020	SELL	$105.46 - $144.13 $4.11 Million - $5.61 Million	-38,929 Reduced 72.39%	14,847 $2.12 Million
Q2 2020 Aug 14, 2020	SELL	$95.68 - $121.88 $2.02 Million - $2.57 Million	-21,061 Reduced 28.14%	53,776 $5.93 Million
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $22.4 Million - $39 Million	-255,266 Reduced 77.33%	74,837 $7.46 Million
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $12.9 Million - $16.9 Million	109,891 Added 49.9%	330,103 $49.3 Million
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $25.3 Million - $28.9 Million	201,832 Added 1098.11%	220,212 $28.2 Million
Q2 2019 Aug 14, 2019	SELL	$125.55 - $144.48 $9.22 Million - $10.6 Million	-73,446 Reduced 79.98%	18,380 $2.62 Million
Q1 2019 May 15, 2019	SELL	$121.81 - $142.95 $8.51 Million - $9.99 Million	-69,889 Reduced 43.22%	91,826 $13.1 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $7.32 Million - $10.5 Million	63,100 Added 63.99%	161,715 $20 Million
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $10.8 Million - $12.1 Million	67,127 Added 213.18%	98,615 $16.6 Million
Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $10.6 Million - $13.3 Million	-72,726 Reduced 69.79%	31,488 $5.43 Million
Q1 2018 May 15, 2018	SELL	$135.59 - $157.16 $9.67 Million - $11.2 Million	-71,302 Reduced 40.62%	104,214 $15.7 Million
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $17.9 Million - $20.5 Million	136,557 Added 350.51%	175,516 $23.6 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $5.56 Million - $6.06 Million	38,959	38,959 $5.7 Million

Others Institutions Holding JAZZ

# of Institutions

584

Shares Held

60.4M

Call Options Held

424K

Put Options Held

190K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.94B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account